Mi M - Search Results

1

Identification of hub genes and key pathways associated with angioimmunoblastic T-cell lymphoma using weighted gene co-expression network analysis.

Li X, Liu Z, Mi M, Zhang C, Xiao Y, Liu X, Wu G, Zhang L. Li X, et al. Among authors: mi m. Cancer Manag Res. 2019 Jun 6;11:5209-5220. doi: 10.2147/CMAR.S185030. eCollection 2019. Cancer Manag Res. 2019. PMID: 31239775 Free PMC article.

2

Interim PET/CT based on visual and semiquantitative analysis predicts survival in patients with diffuse large B-cell lymphoma.

Li X, Sun X, Li J, Liu Z, Mi M, Zhu F, Wu G, Lan X, Zhang L. Li X, et al. Among authors: mi m. Cancer Med. 2019 Sep;8(11):5012-5022. doi: 10.1002/cam4.2404. Epub 2019 Jul 10. Cancer Med. 2019. PMID: 31293092 Free PMC article.

3

lncRNA OSTN-AS1 May Represent a Novel Immune-Related Prognostic Marker for Triple-Negative Breast Cancer Based on Integrated Analysis of a ceRNA Network.

Liu Z, Mi M, Li X, Zheng X, Wu G, Zhang L. Liu Z, et al. Among authors: mi m. Front Genet. 2019 Sep 13;10:850. doi: 10.3389/fgene.2019.00850. eCollection 2019. Front Genet. 2019. PMID: 31572452 Free PMC article.

4

A lncRNA prognostic signature associated with immune infiltration and tumour mutation burden in breast cancer.

Liu Z, Mi M, Li X, Zheng X, Wu G, Zhang L. Liu Z, et al. Among authors: mi m. J Cell Mol Med. 2020 Nov;24(21):12444-12456. doi: 10.1111/jcmm.15762. Epub 2020 Sep 23. J Cell Mol Med. 2020. PMID: 32967061 Free PMC article.

5

miR-30a/SOX4 Double Negative Feedback Loop is modulated by Disulfiram and regulates EMT and Stem Cell-like properties in Breast Cancer.

Liu Z, Mi M, Zheng X, Zhang C, Zhu F, Liu T, Wu G, Zhang L. Liu Z, et al. Among authors: mi m. J Cancer. 2021 Jun 16;12(16):5053-5065. doi: 10.7150/jca.57752. eCollection 2021. J Cancer. 2021. PMID: 34234874 Free PMC article.

6

Gemcitabine, cisplatin, and dexamethasone and ifosfamide, carboplatin, and etoposide regimens have similar efficacy as salvage treatment for relapsed/refractory aggressive lymphoma: A retrospectively comparative study.

Mi M, Zhang C, Liu Z, Wang Y, Li J, Zhang L. Mi M, et al. Medicine (Baltimore). 2020 Dec 4;99(49):e23412. doi: 10.1097/MD.0000000000023412. Medicine (Baltimore). 2020. PMID: 33285732 Free PMC article.

7

Serum metabolomic profiling based on GC/MS helped to discriminate Diffuse Large B-cell Lymphoma patients with different prognosis.

Mi M, Liu Z, Zheng X, Wen Q, Zhu F, Li J, Mungur ID, Zhang L. Mi M, et al. Leuk Res. 2021 Dec;111:106693. doi: 10.1016/j.leukres.2021.106693. Epub 2021 Aug 24. Leuk Res. 2021. PMID: 34455197

8

Disulfiram Improves the Anti-PD-1 Therapy Efficacy by Regulating PD-L1 Expression via Epigenetically Reactivation of IRF7 in Triple Negative Breast Cancer.

Zheng X, Liu Z, Mi M, Wen Q, Wu G, Zhang L. Zheng X, et al. Among authors: mi m. Front Oncol. 2021 Nov 10;11:734853. doi: 10.3389/fonc.2021.734853. eCollection 2021. Front Oncol. 2021. PMID: 34858816 Free PMC article.

9

REV1: A novel biomarker and potential therapeutic target for various cancers.

Zhu N, Zhao Y, Mi M, Lu Y, Tan Y, Fang X, Weng S, Yuan Y. Zhu N, et al. Among authors: mi m. Front Genet. 2022 Sep 29;13:997970. doi: 10.3389/fgene.2022.997970. eCollection 2022. Front Genet. 2022. PMID: 36246647 Free PMC article.

10

Ferroptosis regulator FANCD2 is associated with immune infiltration and predicts worse prognosis in lung adenocarcinoma.

Ye C, Lu Y, Yuan Z, Mi M, Qi L, Yuan Y, Weng S. Ye C, et al. Among authors: mi m. Front Genet. 2022 Oct 4;13:922914. doi: 10.3389/fgene.2022.922914. eCollection 2022. Front Genet. 2022. PMID: 36267413 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

370 results

Search Page

Filters